Anfosso F, Leyris R, Charpin J
Biomedicine. 1979 Jul;30(3):168-72.
The capacity of amoxicillin to elicit allergenic reactions in vitro was determined on benzyl-penicillin sensitive patients. RAST and histamine release were performed on blood of these patients using B pen linked to human serum albumin (BPO-HSA) as allergen. A relationship was noted between the results of the in vitro tests and the date of the allergic manifestations. When results of RAST and histamine release were significant, amoxicillin was tested for its capacity to elicit histamine release and to inhibit RAST performed with BPO-HSA. A cross-allergenicity was observed in six sera out of eight. The results suggested that amoxicillin may be capable to react with cell-bound or serum IgE to give hypersensitive manifestations in some penicillin sensitive patients.
在对苄青霉素敏感的患者身上测定了阿莫西林引发体外过敏反应的能力。使用与人血清白蛋白相连的苄青霉素(BPO-HSA)作为变应原,对这些患者的血液进行了放射性变应原吸附试验(RAST)和组胺释放试验。体外试验结果与过敏表现的日期之间存在关联。当RAST和组胺释放结果显著时,检测了阿莫西林引发组胺释放以及抑制用BPO-HSA进行的RAST的能力。在八份血清中有六份观察到交叉变应性。结果表明,在一些青霉素敏感患者中,阿莫西林可能能够与细胞结合型或血清免疫球蛋白E(IgE)发生反应,从而产生过敏表现。